These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37405348)

  • 1. The 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus.
    Gent DG; Rebecca D
    Eur Cardiol; 2023; 18():e16. PubMed ID: 37405348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [2022 ESC guidelines on cardio-oncology : Understanding and treating cardiovascular side effects from cancer therapy].
    Michel L; Totzeck M; Rassaf T
    Herz; 2023 Feb; 48(1):15-22. PubMed ID: 36441175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment.
    Lee GA; Aktaa S; Baker E; Gale CP; Yaseen IF; Gulati G; Asteggiano R; Szmit S; Cohen-Solal A; Abdin A; Jurczak W; Garrido Lopez P; Sverdlov AL; Tocchetti CG; Barac A; Parrini I; Zamorano P; Iakobishvili Z; Pudil R; Badimon L; Kirby AM; Blaes AH; Farmakis D; Curigliano G; Stephens R; Lyon AR; Lopez-Fernandez T
    Eur Heart J Qual Care Clin Outcomes; 2022 Dec; 9(1):1-7. PubMed ID: 36316010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
    Lyon AR; Dent S; Stanway S; Earl H; Brezden-Masley C; Cohen-Solal A; Tocchetti CG; Moslehi JJ; Groarke JD; Bergler-Klein J; Khoo V; Tan LL; Anker MS; von Haehling S; Maack C; Pudil R; Barac A; Thavendiranathan P; Ky B; Neilan TG; Belenkov Y; Rosen SD; Iakobishvili Z; Sverdlov AL; Hajjar LA; Macedo AVS; Manisty C; Ciardiello F; Farmakis D; de Boer RA; Skouri H; Suter TM; Cardinale D; Witteles RM; Fradley MG; Herrmann J; Cornell RF; Wechelaker A; Mauro MJ; Milojkovic D; de Lavallade H; Ruschitzka F; Coats AJS; Seferovic PM; Chioncel O; Thum T; Bauersachs J; Andres MS; Wright DJ; López-Fernández T; Plummer C; Lenihan D
    Eur J Heart Fail; 2020 Nov; 22(11):1945-1960. PubMed ID: 32463967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future steps in cardio-oncology-a national multidisciplinary survey among healthcare professionals in the Netherlands.
    Koop Y; Teske AJ; Wanders I; Meijer H; Kaanders JHAMH; Manintveld OC; Hassing HC; Vermeulen H; Maas AHEM; van Spronsen DJ; Atsma F; El Messaoudi S
    J Cancer Surviv; 2023 Aug; 17(4):1131-1138. PubMed ID: 35118579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in cardio-oncology: a report from the 'Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019'.
    Anker MS; Hadzibegovic S; Lena A; Belenkov Y; Bergler-Klein J; de Boer RA; Farmakis D; von Haehling S; Iakobishvili Z; Maack C; Pudil R; Skouri H; Cohen-Solal A; Tocchetti CG; Coats AJS; Seferović PM; Lyon AR;
    ESC Heart Fail; 2019 Dec; 6(6):1140-1148. PubMed ID: 31884717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
    Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR
    Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practices in management of cancer treatment-related cardiovascular toxicity: A cardio-oncology survey.
    Jovenaux L; Cautela J; Resseguier N; Pibarot M; Taouqi M; Orabona M; Pinto J; Peyrol M; Barraud J; Laine M; Bonello L; Paganelli F; Barlesi F; Thuny F
    Int J Cardiol; 2017 Aug; 241():387-392. PubMed ID: 28365180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
    Zamorano JL; Lancellotti P; Rodriguez Muñoz D; Aboyans V; Asteggiano R; Galderisi M; Habib G; Lenihan DJ; Lip GY; Lyon AR; Lopez Fernandez T; Mohty D; Piepoli MF; Tamargo J; Torbicki A; Suter TM; Zamorano JL; Aboyans V; Achenbach S; Agewall S; Badimon L; Barón-Esquivias G; Baumgartner H; Bax JJ; Bueno H; Carerj S; Dean V; Erol Ç; Fitzsimons D; Gaemperli O; Kirchhof P; Kolh P; Lancellotti P; Lip GY; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Roffi M; Torbicki A; Vaz Carneiro A; Windecker S; ; ;
    Eur J Heart Fail; 2017 Jan; 19(1):9-42. PubMed ID: 27565769
    [No Abstract]   [Full Text] [Related]  

  • 10. What Does a Cardio-oncology Service Offer to the Oncologist and the Haematologist?
    Andres MS; Pan J; Lyon AR
    Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):483-493. PubMed ID: 33832839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Association for Acute Cardio Vascular Care (ACVC), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS).
    Richter D; Guasti L; Walker D; Lambrinou E; Lionis C; Abreu A; Savelieva I; Fumagalli S; Bo M; Rocca B; Jensen MT; Pierard L; Sudano I; Aboyans V; Asteggiano R
    Eur J Prev Cardiol; 2022 Feb; 29(1):216-227. PubMed ID: 34270717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
    Pudil R; Mueller C; Čelutkienė J; Henriksen PA; Lenihan D; Dent S; Barac A; Stanway S; Moslehi J; Suter TM; Ky B; Štěrba M; Cardinale D; Cohen-Solal A; Tocchetti CG; Farmakis D; Bergler-Klein J; Anker MS; Von Haehling S; Belenkov Y; Iakobishvili Z; Maack C; Ciardiello F; Ruschitzka F; Coats AJS; Seferovic P; Lainscak M; Piepoli MF; Chioncel O; Bax J; Hulot JS; Skouri H; Hägler-Laube ES; Asteggiano R; Fernandez TL; de Boer RA; Lyon AR
    Eur J Heart Fail; 2020 Nov; 22(11):1966-1983. PubMed ID: 33006257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardio-oncology: where do we stand for in Belgium?
    Lancellotti P; De Pauw M; Claeys M
    Acta Cardiol; 2021 Apr; 76(2):204-208. PubMed ID: 31967938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer patient and cardiology.
    Zamorano JL; Gottfridsson C; Asteggiano R; Atar D; Badimon L; Bax JJ; Cardinale D; Cardone A; Feijen EAM; Ferdinandy P; López-Fernández T; Gale CP; Maduro JH; Moslehi J; Omland T; Plana Gomez JC; Scott J; Suter TM; Minotti G
    Eur J Heart Fail; 2020 Dec; 22(12):2290-2309. PubMed ID: 32809231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
    Zamorano JL; Lancellotti P; Rodriguez Muñoz D; Aboyans V; Asteggiano R; Galderisi M; Habib G; Lenihan DJ; Lip GYH; Lyon AR; Lopez Fernandez T; Mohty D; Piepoli MF; Tamargo J; Torbicki A; Suter TM;
    Eur Heart J; 2016 Sep; 37(36):2768-2801. PubMed ID: 27567406
    [No Abstract]   [Full Text] [Related]  

  • 16. Brazilian cardio-oncology: the 10-year experience of the Instituto do Cancer do Estado de Sao Paulo.
    Costa IBSDS; Bittar CS; Fonseca SMR; E Silva CMPD; Dos Santos Rehder MHH; Rizk SI; Cruz CBBV; Figueiredo CS; de A Andrade FT; Barberino LA; de S Costa FA; Machado LP; González TB; Almeida MPC; Fukushima JT; Kalil Filho R; Hajjar LA
    BMC Cardiovasc Disord; 2020 Apr; 20(1):206. PubMed ID: 32345217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.
    Parent S; Pituskin E; Paterson DI
    Can J Cardiol; 2016 Jul; 32(7):847-51. PubMed ID: 27343743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac computed tomographic imaging in cardio-oncology: An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT). Endorsed by the International Cardio-Oncology Society (ICOS).
    Lopez-Mattei J; Yang EH; Baldassarre LA; Agha A; Blankstein R; Choi AD; Chen MY; Meyersohn N; Daly R; Slim A; Rochitte C; Blaha M; Whelton S; Dzaye O; Dent S; Milgrom S; Ky B; Iliescu C; Mamas MA; Ferencik M
    J Cardiovasc Comput Tomogr; 2023; 17(1):66-83. PubMed ID: 36216699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardio-oncology: the new frontier of clinical and preventive cardiology.
    Paris S; Tarantini L; Navazio A; Faggiano P
    Monaldi Arch Chest Dis; 2020 Jun; 90(2):. PubMed ID: 32571000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
    Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
    Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.